GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| aTYR PHARMA INC (ATYR) | 8/7/2026 4:17:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $69,825,000 | EPS -$0.11 | ||
| aTYR PHARMA INC (ATYR) | 8/7/2026 4:05:51 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $69,825,000 | EPS -$0.11 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/15/2026 4:13:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $79,654,000 | EPS -$0.11 | ||
| aTYR PHARMA INC (ATYR) | 5/15/2026 8:03:52 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $79,654,000 | EPS -$0.11 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 3/26/2026 4:10:05 PM | View | Proxy | SEC | Y 2025 | ||||||
| aTYR PHARMA INC (ATYR) | 3/5/2026 4:26:38 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $190,000 -19.1% | Assets $93,003,000 | EPS -$0.80 | |
| aTYR PHARMA INC (ATYR) | 3/5/2026 4:05:16 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $0 | Assets $93,003,000 | EPS -$0.14 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/6/2025 4:34:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $190,000 | Assets $106,652,000 | EPS -$0.26 | |
| aTYR PHARMA INC (ATYR) | 11/6/2025 4:12:02 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $190,000 | Assets $106,652,000 | EPS -$0.26 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/8/2025 6:08:07 AM | View | Correction | SEC | 2Q 2025 | ||||||
| aTYR PHARMA INC (ATYR) | 8/7/2025 4:14:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $101,534,000 | EPS -$0.22 | ||
| aTYR PHARMA INC (ATYR) | 8/7/2025 4:04:10 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $0 | Assets $101,534,000 | EPS -$0.22 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 5/7/2025 4:16:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $97,245,000 | EPS -$0.17 | ||
| aTYR PHARMA INC (ATYR) | 5/7/2025 4:04:42 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $0 | Assets $97,245,000 | EPS -$0.17 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 3/19/2025 4:11:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| aTYR PHARMA INC (ATYR) | 3/13/2025 5:24:13 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $235,000 -33.4% | Assets $96,830,000 | EPS -$0.86 | |
| aTYR PHARMA INC (ATYR) | 3/13/2025 4:04:41 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $0 | Assets $96,830,000 | EPS -$0.17 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/7/2024 4:24:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $91,616,000 | EPS -$0.23 | ||
| aTYR PHARMA INC (ATYR) | 11/7/2024 4:07:54 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $0 | Assets $91,616,000 | EPS -$0.23 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/13/2024 4:19:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $105,939,000 | EPS -$0.23 | ||
| aTYR PHARMA INC (ATYR) | 8/13/2024 4:04:10 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $0 | Assets $105,939,000 | EPS -$0.23 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 5/2/2024 4:19:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $235,000 | Assets $113,251,000 | EPS -$0.23 | |
| aTYR PHARMA INC (ATYR) | 5/2/2024 4:05:30 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $235,000 | Assets $113,251,000 | EPS -$0.23 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 4/5/2024 4:01:40 PM | View | Proxy | SEC | Y 2023 | ||||||
| aTYR PHARMA INC (ATYR) | 3/14/2024 4:49:12 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $353,000 -96.6% | Assets $120,653,000 | EPS -$0.94 | |
| aTYR PHARMA INC (ATYR) | 3/14/2024 4:02:23 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $0 | Assets $120,653,000 | EPS -$0.25 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/9/2023 4:26:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $353,000 | Assets $125,069,000 | EPS -$0.20 | |
| aTYR PHARMA INC (ATYR) | 11/9/2023 4:10:22 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $353,000 | Assets $125,069,000 | EPS -$0.20 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/9/2023 4:29:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $132,747,000 | EPS -$0.22 | ||
| aTYR PHARMA INC (ATYR) | 8/9/2023 4:15:00 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $0 | Assets $132,747,000 | EPS -$0.22 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 5/9/2023 4:24:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $136,838,000 | EPS -$0.29 | ||
| aTYR PHARMA INC (ATYR) | 5/9/2023 4:10:12 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $0 | Assets $136,838,000 | EPS -$0.29 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 3/29/2023 4:13:51 PM | View | Proxy | SEC | Y 2022 | ||||||
| aTYR PHARMA INC (ATYR) | 3/14/2023 4:30:27 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $10,386,000 | Assets $95,786,000 | EPS -$1.60 | |
| aTYR PHARMA INC (ATYR) | 3/9/2023 4:04:51 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $10,386,000 | Assets $95,786,000 | EPS -$0.26 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/14/2022 8:28:03 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $96,055,000 | EPS -$0.46 | ||
| aTYR PHARMA INC (ATYR) | 11/10/2022 4:18:26 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $0 | Assets $96,055,000 | EPS -$0.46 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/15/2022 5:17:30 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $96,016,000 | EPS -$0.44 | ||
| aTYR PHARMA INC (ATYR) | 8/15/2022 4:25:31 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $96,016,000 | EPS -$0.44 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/10/2022 4:39:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $104,776,000 | EPS -$0.44 | ||
| aTYR PHARMA INC (ATYR) | 5/9/2022 4:10:47 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $104,776,000 | EPS -$0.44 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 3/22/2022 4:40:22 PM | View | Proxy | SEC | Y 2021 | ||||||
| aTYR PHARMA INC (ATYR) | 3/15/2022 5:06:04 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $115,537,000 | EPS -$1.77 | ||
| aTYR PHARMA INC (ATYR) | 3/14/2022 4:21:21 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $0 | Assets $115,537,000 | EPS -$0.21 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/12/2021 4:15:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $123,916,000 | EPS -$0.42 | ||
| aTYR PHARMA INC (ATYR) | 11/10/2021 4:13:20 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $123,916,000 | EPS -$0.42 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 8/11/2021 4:42:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $48,995,000 | EPS -$0.64 | ||
| aTYR PHARMA INC (ATYR) | 8/10/2021 4:19:59 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $48,995,000 | EPS -$0.64 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/14/2021 4:14:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $55,128,000 | EPS -$0.51 | ||
| aTYR PHARMA INC (ATYR) | 5/13/2021 4:15:53 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $55,128,000 | EPS -$0.51 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 3/24/2021 6:11:57 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $10,455,000 +2,377.5% | Assets $38,726,000 | EPS -$1.77 | |
| aTYR PHARMA INC (ATYR) | 3/24/2021 6:05:19 AM | View | Proxy | SEC | Y 2020 | ||||||
| aTYR PHARMA INC (ATYR) | 3/23/2021 4:19:48 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $2,053,000 +1,325.7% | Assets $38,726,000 | EPS -$0.46 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/13/2020 5:36:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $148,000 -19.6% | Assets $41,636,000 | EPS -$0.68 | |
| aTYR PHARMA INC (ATYR) | 11/12/2020 4:17:29 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $148,000 -19.6% | Assets $41,636,000 | EPS -$0.68 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/13/2020 4:53:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $189,000 +101.1% | Assets $47,562,000 | EPS -$0.69 | |
| aTYR PHARMA INC (ATYR) | 8/13/2020 4:07:24 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $189,000 +101.1% | Assets $47,562,000 | EPS -$0.69 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 5/12/2020 5:12:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,065,000 | Assets $54,447,000 | EPS $0.25 | |
| aTYR PHARMA INC (ATYR) | 5/12/2020 5:01:12 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $8,065,000 | Assets $54,447,000 | EPS $0.25 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 4/2/2020 4:01:19 PM | View | Proxy | SEC | Y 2019 | ||||||
| aTYR PHARMA INC (ATYR) | 3/26/2020 4:22:16 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $422,000 | Assets $36,188,000 | EPS -$7.03 | |
| aTYR PHARMA INC (ATYR) | 3/26/2020 4:06:55 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $144,000 | Assets $36,188,000 | EPS -$1.54 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 11/14/2019 4:25:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $184,000 | Assets $43,745,000 | EPS -$1.47 | |
| aTYR PHARMA INC (ATYR) | 11/14/2019 4:08:38 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $184,000 | Assets $43,745,000 | EPS -$1.47 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 8/14/2019 5:04:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $94,000 | Assets $48,762,000 | EPS -$1.80 | |
| aTYR PHARMA INC (ATYR) | 8/14/2019 9:47:54 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $94,000 | Assets $48,762,000 | EPS -$1.80 | Export Earnings Model | |
| aTYR PHARMA INC (ATYR) | 5/14/2019 4:45:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $49,915,000 | EPS -$2.54 | ||
| aTYR PHARMA INC (ATYR) | 5/13/2019 4:16:44 PM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $49,915,000 | EPS -$2.54 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 3/28/2019 4:02:08 PM | View | Proxy | SEC | Y 2018 | ||||||
| aTYR PHARMA INC (ATYR) | 3/26/2019 5:49:01 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $52,746,000 | EPS -$16.11 | ||
| aTYR PHARMA INC (ATYR) | 3/25/2019 4:17:29 PM | View | Financials | Earnings | SEC | Y 2018 | Assets $52,746,000 | EPS -$2.92 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 11/14/2018 5:07:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $59,774,000 | EPS -$3.33 | ||
| aTYR PHARMA INC (ATYR) | 11/13/2018 4:17:45 PM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $59,774,000 | EPS -$3.33 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 8/14/2018 5:00:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $68,308,000 | EPS -$4.88 | ||
| aTYR PHARMA INC (ATYR) | 8/14/2018 4:50:16 PM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $68,308,000 | EPS -$4.88 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/29/2018 4:00:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $78,470,000 | EPS -$5.01 | ||
| aTYR PHARMA INC (ATYR) | 5/14/2018 6:46:17 AM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $78,470,000 | EPS -$5.01 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 4/3/2018 4:02:13 PM | View | Proxy | SEC | Y 2017 | ||||||
| aTYR PHARMA INC (ATYR) | 3/20/2018 5:07:04 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $89,355,000 | EPS -$26.13 | ||
| aTYR PHARMA INC (ATYR) | 3/19/2018 4:09:56 PM | View | Financials | Earnings | SEC | Y 2017 | Assets $89,355,000 | EPS -$5.39 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 11/14/2017 4:45:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $94,487,000 | EPS -$6.06 | ||
| aTYR PHARMA INC (ATYR) | 11/14/2017 4:29:45 PM | View | Financials | Earnings | SEC | 3Q 2017 | Assets $94,487,000 | EPS -$6.06 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 8/14/2017 5:26:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $61,472,000 | EPS -$7.13 | ||
| aTYR PHARMA INC (ATYR) | 8/14/2017 4:47:01 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $61,472,000 | EPS -$7.13 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/11/2017 4:24:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $65,735,000 | EPS -$7.90 | ||
| aTYR PHARMA INC (ATYR) | 5/11/2017 4:10:23 PM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $65,735,000 | EPS -$7.90 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 3/30/2017 4:00:49 PM | View | Proxy | SEC | Y 2016 | ||||||
| aTYR PHARMA INC (ATYR) | 3/16/2017 4:16:52 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $80,524,000 | EPS -$34.16 | ||
| aTYR PHARMA INC (ATYR) | 3/16/2017 4:10:58 PM | View | Financials | Earnings | SEC | Y 2016 | Assets $80,524,000 | EPS -$0.53 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 11/14/2016 3:41:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $85,925,000 | EPS -$0.58 | ||
| aTYR PHARMA INC (ATYR) | 11/14/2016 7:30:21 AM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $85,925,000 | EPS -$0.58 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 8/10/2016 4:19:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $100,486,000 | EPS -$0.65 | ||
| aTYR PHARMA INC (ATYR) | 8/10/2016 4:16:44 PM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $100,486,000 | EPS -$0.65 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 5/11/2016 4:11:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $115,125,000 | EPS -$0.68 | ||
| aTYR PHARMA INC (ATYR) | 5/11/2016 4:05:25 PM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $115,125,000 | EPS -$0.68 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 4/12/2016 5:15:24 PM | View | Proxy | SEC | Y 2015 | ||||||
| aTYR PHARMA INC (ATYR) | 3/30/2016 4:13:31 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $129,675,000 | EPS -$3.03 | ||
| aTYR PHARMA INC (ATYR) | 3/30/2016 4:05:15 PM | View | Financials | Earnings | SEC | Y 2015 | Assets $129,675,000 | EPS -$0.70 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 11/10/2015 4:38:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $141,369,000 | EPS -$0.48 | ||
| aTYR PHARMA INC (ATYR) | 11/10/2015 4:25:25 PM | View | Financials | Earnings | SEC | 3Q 2015 | Assets $141,369,000 | EPS -$0.48 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 8/12/2015 4:18:55 PM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $153,081,000 | EPS -$0.74 | ||
| aTYR PHARMA INC (ATYR) | 8/12/2015 4:15:59 PM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $153,081,000 | EPS -$0.74 | Export Earnings Model | ||
| aTYR PHARMA INC (ATYR) | 6/18/2015 4:22:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $59,905,000 | EPS -$9.39 | ||
| aTYR PHARMA INC (ATYR) | 6/18/2015 4:20:52 PM | View | Financials | Earnings | SEC | 1Q 2015 | Assets $59,905,000 | EPS -$9.39 | Export Earnings Model |